Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

Josephine D. Kahn, Kothai Parthiban, Peter Slavny, Aaron Arvey, Marc Presler, Jamie Nosbisch, Adrienne Rothschilds, Allan Capili, Teresa Barata, Joana Martins, Jiang Zhu, Robert Kamen, Robert Tepper, Ton N. Schumacher, Lioudmila Tchistiakova, Divya Mathur · 2026

Read Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate by Josephine D. Kahn, Kothai Parthiban, Peter Slavny, Aaron Arvey, Marc Presler, Jamie Nosbisch, Adrienne Rothschilds, Allan Capili, Teresa Barata, Joana Martins, Jiang Zhu, Robert Kamen, Robert Tepper, Ton N. Schumacher, Lioudmila Tchistiakova, Divya Mathur (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13398103.txt.

Description

Josephine D Kahn and co-authors engineer an immune signal that switches on only inside tumours. Their 2026 study tackles interleukin-12, a potent immune activator whose body-wide action causes heavy side effects that have blocked its use against solid cancers. The design keeps IL-12 tied up until the protein meets a matrix marker found across tumours, fibronectin EDB.

A two-armed antibody holds the signal in a competitive grip; crowding at the tumour marker pries it open. Computer modelling first set the binding strengths needed, then phage screening and library design produced switches with the right grip. Lab tests confirmed activation depended on the tumour marker, a step toward strong immune therapy with a wider safety margin.

Catalog record

CREATORJosephine D. Kahn, Kothai Parthiban, Peter Slavny, Aaron Arvey, Marc Presler, Jamie Nosbisch, Adrienne Rothschilds, Allan Capili, Teresa Barata, Joana Martins, Jiang Zhu, Robert Kamen, Robert Tepper, Ton N. Schumacher, Lioudmila Tchistiakova, Divya Mathur
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61091
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13398103

Browse the full library · About the Tower of Babel